• 1
    Rapaport FT. The case for a living emotionally related international kidney donor exchange registry. Transplantation Proc 1986; 18(Suppl 2): 59.
  • 2
    Ross LF, Rubin DT, Siegler M, Josephson MA, Thistlethwaite JR Jr, Woodle ES. Ethics of a paired-kidney-exchange program. N Engl J Med 1997; 336: 7521755.
  • 3
    Ross LF, Woodle ES. Ethical issues in increasing living kidney donations by expanding kidney paired exchange programs. Transplantation 2000; 69: 5391543.
  • 4
    Park K, Lee JH, Huh KH, Kim SI and Kim YS. Exchange living-donor kidney transplantation: diminution of donor organ shortage. Transplantation Proc 2004; 36: 29492951.
  • 5
    McLellan F. US surgeons do first “triple-swap” kidney transplantation. Lancet 2003; 362: 456.
  • 6
    Delmonico FL, Morrissey PE, Lipkowitz GS et al. Donor kidney exchanges. Am J Transplant 2004; 4: 16281634.
  • 7
    Klerk M De, Luchtenburg AE, Zuidema WC et al. Acceptability and feasibility of crossoverkidney transplantation. In: GutmannT, DaarAS, SellsRA, LandW (Eds). Ethical, Legal and Social Issues in Organ Transplantation. D-49525 Lengerich: PABST science publishers, 2004: 255262. (ISBN 3–89967–017–5 (Europe), ISBN 1–59326–063–6 ( USA ))
  • 8
    Kranenburg LW, Visak T, Weimar W et al. Starting a crossover kidney transplantation program in the Netherlands: ethical and psychological considerations. Transplantation 2004; 78: 194197.
  • 9
    Montgomery RA, Zachary AA, Racusen LC et al. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation 2000; 70: 887895.
  • 10
    Jordan SC, Vo A, Bunnapradist S et al. Intravenous immune globulin treatment inhibits cross match positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients. Transplantation 2003;76: 631636.
  • 11
    Gilbert JC, Brigham L, Batty Jr DS and Veatch RM. The nondirected living donor program: a model for cooperative donation, recovery and allocation of living donor kidneys. Am J Transplant 2005;5: 167174.
  • 12
    Ross LF and Zenios S. Restricting living-donor-cadaver-donor exchanges to ensure that standard blood type O wait-list candidates benefit. Transplantation 2004; 78: 641646.